Abstract:During the course of disease progression, changes in nucleic acid and non-nucleic acid marker content can serve as indicators for disease diagnosis. The clustered regularly spaced short palindromic repeats (CRISPR) /Cas12a system, as a natural amplifier, has been widely exploited to construct amplified detection platforms for various analytes detection owing to its advantages of simplicity, high activity, and strong specificity. Nowadays, most of the focus use of nucleic acid chains as response elements to activate Cas12a. So, the development of switchable crRNA-based detection methods is still urgent to be excavated to expand its applications in non-nucleic acids analytes quantification. A powerful and universal fluorescent sensing platform for the detection of non-nucleic acid analytes based on programmable switch of CRISPR/Cas12 activity via modulating crRNA conformation is proposed. In this system, two state, in which the crRNA sequence is partially caged with the specially designed blocker DNA ("locked state" ) and the native crRNA is regained after blocker DNA get lost ("unlocked state" ) are modulated through target recognition. When the target is present, the function of the CRISPR/Cas12a system can rapidly reinstated by switching lockeing to unlocking to cleave fluorescent reporters for signal output. As proof-of-concept example, this platform is demonstrated to enable to detect three analytes including adenosine triphosphate (ATP), glutathione (GSH), formamidopyrimidine-DNA glycosylase (Fpg) with high specificity and good sensitivity (LODATP = 0.046 μM, LODGSH = 0.1 μM, LODFpg = 0.2 U/mL). Moreover, by importing programmable modular, a set of CRISPR/Cas12 system-based logic gate is successfully constructed. Our constructed switchable crRNA-based sensing platform is universal, in which the target binding event is converting into the tunable trans-cleavage of ssDNA reporter via Cas12a, thus this platform can be expanded for detecting a wide spectrum of analytes by redesigning the corresponding sequence for target recognition. With its capacities of universality, robustness, convenience, and programmability, the present platform indeed provides a useful and practical tool for molecular diagnosis and biomedicine research.

CRISPR/Cas12a-triggered ordered concatemeric DNA probes signal-on/off multifunctional analytical sensing system for ultrasensitive detection of thalassemia

A Simple, Rapid, and Highly Sensitive Electrochemical DNA Sensor for the Detection of α- and β-Thalassemia in China

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Noninvasive Prenatal Genetic Screening of Cell-Free Fetal DNA for Early Prediction of β-Thalassemia Using Fiber Optic Nanogold-Linked Sorbent Assay

A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules

A boosting upconversion luminescent resonance energy transfer and biomimetic periodic chip integrated CRISPR/Cas12a biosensor for functional DNA regulated transduction of non-nucleic acid targets

Multifunctional organophosphorus ligand-templated poly(polyoxotungstate) with potential in building genosensor for thalassemia genetic detection

AND Logic-Gate-Based CRISPR/Cas12a Biosensing Platform for the Sensitive Colorimetric Detection of Dual Mirnas.

An Exceptional and Universal DNA Walker Amplified “One-to-many” CRISPR/Cas12a-Mediated Fluorescent Biosensor for Ultrasensitive Detection of Non-DNA Biomarkers

A CRISPR-Cas12a-based electrochemical biosensor for the detection of microphthalmia-associated transcription factor

Target-allele-specific probe single-base extension (TASP-SBE): a novel MALDI-TOF-MS strategy for multi-variants analysis and its application in simultaneous detection of α-/β-thalassemia mutations

Programmable CRISPR/Cas12a Activity by Adjusting Guide RNA Conformation for Non-nucleic Acid Markers Analysis and Logic Gate Applications

A Highly Sensitive CRISPR‐Empowered Surface Plasmon Resonance Sensor for Diagnosis of Inherited Diseases with Femtomolar‐Level Real‐Time Quantification

A dual-mode strategy based on β-galactosidase and target-induced DNA polymerase protection for transcription factor detection using colorimetry and a glucose meter

Cas12a/crRNA recognition initiated self-priming mediated chain extension for colorimetric Cell-free DNA (cfDNA) analysis

Development of Cas12a-Based Cell-Free Small-Molecule Biosensors via Allosteric Regulation of CRISPR Array Expression

Ultrasensitive electrochemical DNA sensor based on the target induced structural switching and surface-initiated enzymatic polymerization.

Holographic Optical Tweezers and Boosting Upconversion Luminescent Resonance Energy Transfer Combined Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas12a Biosensors

Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing

SNPscan Combined With CNVplex as a High‐Performance Diagnostic Method for Thalassemia

A Nested Asymmetric PCR Melting Curve Assay for One-Step Genotyping of Nondeletional α-Thalassemia Mutations